News > Serum Institute gets SEC thumbs up; Bharat Biotech proposal being discussed

Serum Institute gets SEC thumbs up; Bharat Biotech proposal being discussed

The expert panel that is advising the Drug Controller General of India (DCGI) on Covid-19 vaccines has given an in-principle nod today to the AstraZeneca-Oxford vaccine candidate, which Pune's Serum Institute of India will make and market here, say sources in the know.

While US giant Pfizer did not come to present its case on Friday before the Subject Expert Committee (SEC), Hyderabad-based vaccine major Bharat Biotech has presented its case.